Alpha Tau Medical (DRTS) News Today → Trump’s Gift Could Unleash $51 Billion in New Wealth (From Wealthpin Pro) (Ad) Free DRTS Stock Alerts $2.51 +0.01 (+0.40%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 25, 2024 | americanbankingnews.comEquities Analysts Offer Predictions for Alpha Tau Medical Ltd.'s FY2024 Earnings (NASDAQ:DRTS)May 24, 2024 | marketbeat.comFY2024 EPS Estimates for Alpha Tau Medical Ltd. Raised by HC Wainwright (NASDAQ:DRTS)Alpha Tau Medical Ltd. (NASDAQ:DRTS - Free Report) - Research analysts at HC Wainwright raised their FY2024 earnings estimates for shares of Alpha Tau Medical in a research note issued on Wednesday, May 22nd. HC Wainwright analyst Y. Chen now forecasts that the company will post earnings per sharMay 24, 2024 | americanbankingnews.comAlpha Tau Medical Ltd. Forecasted to Earn Q2 2025 Earnings of ($0.13) Per Share (NASDAQ:DRTS)May 23, 2024 | marketbeat.comAlpha Tau Medical Ltd. (NASDAQ:DRTS) to Post Q2 2025 Earnings of ($0.13) Per Share, HC Wainwright ForecastsAlpha Tau Medical Ltd. (NASDAQ:DRTS - Free Report) - Equities research analysts at HC Wainwright issued their Q2 2025 earnings per share estimates for shares of Alpha Tau Medical in a research report issued on Wednesday, May 22nd. HC Wainwright analyst Y. Chen anticipates that the company will poMay 23, 2024 | americanbankingnews.comAlpha Tau Medical (NASDAQ:DRTS) Receives Buy Rating from HC WainwrightMay 22, 2024 | marketbeat.comAlpha Tau Medical (NASDAQ:DRTS) Stock Rating Reaffirmed by HC WainwrightHC Wainwright reissued a "buy" rating and issued a $9.00 price target on shares of Alpha Tau Medical in a report on Wednesday.May 21, 2024 | markets.businessinsider.comPiper Sandler Keeps Their Buy Rating on Alpha Tau Medical Ltd (DRTS)May 21, 2024 | marketbeat.comAlpha Tau Medical (NASDAQ:DRTS) Posts Quarterly Earnings Results, Beats Estimates By $0.02 EPSAlpha Tau Medical (NASDAQ:DRTS - Get Free Report) posted its quarterly earnings data on Monday. The company reported ($0.11) EPS for the quarter, beating the consensus estimate of ($0.13) by $0.02.May 21, 2024 | globenewswire.comAlpha Tau to Present at the Jefferies Global Healthcare ConferenceMay 21, 2024 | finanznachrichten.deAlpha Tau Medical Ltd.: Alpha Tau Medical Announces First Quarter 2024 Financial Results and Provides Corporate UpdateMay 20, 2024 | globenewswire.comAlpha Tau Medical Announces First Quarter 2024 Financial Results and Provides Corporate UpdateMay 16, 2024 | marketbeat.comAlpha Tau Medical (NASDAQ:DRTS) Earns "Buy" Rating from HC WainwrightHC Wainwright reissued a "buy" rating and issued a $9.00 price target on shares of Alpha Tau Medical in a research note on Thursday.May 13, 2024 | globenewswire.comAlpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal CancerMay 6, 2024 | globenewswire.comAlpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect in Pancreatic Murine Tumor Models at ESTRO 2024 Congress in GlasgowMay 1, 2024 | globenewswire.comAlpha Tau to Participate in May Investor ConferencesMarch 31, 2024 | marketbeat.comAlpha Tau Medical Ltd. (NASDAQ:DRTS) Sees Large Increase in Short InterestAlpha Tau Medical Ltd. (NASDAQ:DRTS - Get Free Report) was the recipient of a large growth in short interest in the month of March. As of March 15th, there was short interest totalling 34,900 shares, a growth of 22.5% from the February 29th total of 28,500 shares. Approximately 0.1% of the company's stock are short sold. Based on an average daily volume of 34,500 shares, the days-to-cover ratio is currently 1.0 days.March 25, 2024 | globenewswire.comAlpha Tau to Present at the Jefferies Radiopharma Innovation SummitMarch 15, 2024 | marketbeat.comAlpha Tau Medical Ltd. Expected to Earn FY2024 Earnings of ($0.49) Per Share (NASDAQ:DRTS)Alpha Tau Medical Ltd. (NASDAQ:DRTS - Free Report) - Equities researchers at HC Wainwright lifted their FY2024 earnings per share estimates for shares of Alpha Tau Medical in a research report issued on Tuesday, March 12th. HC Wainwright analyst Y. Chen now expects that the company will post earnMarch 12, 2024 | markets.businessinsider.comBuy Rating Affirmed: Anticipating Alpha Tau Medical’s Clinical Milestones and Growth Potential in 2024March 7, 2024 | globenewswire.comAlpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate UpdateFebruary 26, 2024 | globenewswire.comAlpha Tau to Participate in Barclays 26th Annual Global Healthcare ConferenceJanuary 8, 2024 | benzinga.comAlpha Tau Medical Stock (NASDAQ:DRTS), Quotes and News SummaryDecember 20, 2023 | finance.yahoo.comAlpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceDecember 16, 2023 | marketbeat.comAlpha Tau Medical Ltd. (NASDAQ:DRTS) Short Interest Up 12.9% in NovemberAlpha Tau Medical Ltd. (NASDAQ:DRTS - Get Free Report) was the target of a large growth in short interest during the month of November. As of November 30th, there was short interest totalling 73,500 shares, a growth of 12.9% from the November 15th total of 65,100 shares. Approximately 0.2% of the shares of the stock are sold short. Based on an average trading volume of 25,700 shares, the days-to-cover ratio is presently 2.9 days.December 15, 2023 | marketbeat.comAlpha Tau Medical (NASDAQ:DRTS) Now Covered by Analysts at CitigroupCitigroup assumed coverage on shares of Alpha Tau Medical in a report on Friday. They issued a "buy" rating and a $8.00 target price on the stock.November 28, 2023 | finance.yahoo.comAlpha Tau Announces Highly Promising Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic CancerNovember 20, 2023 | finance.yahoo.comAlpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck CancerNovember 17, 2023 | markets.businessinsider.comAnalyst Ratings for Alpha Tau MedicalNovember 16, 2023 | msn.comAlpha Tau Medical GAAP EPS of $0.31October 30, 2023 | finance.yahoo.comAlpha Tau Enters Into Long-Term Lease of Site in New Hampshire for Second U.S. Manufacturing FacilitySeptember 16, 2023 | finance.yahoo.comHere's Why We're Not Too Worried About Alpha Tau Medical's (NASDAQ:DRTS) Cash Burn SituationSeptember 14, 2023 | stockhouse.comAlpha Tau Treats First Patient with Advanced Inoperable Pancreatic Cancer at Israel's Hadassah Medical CenterSeptember 1, 2023 | marketbeat.comCantor Fitzgerald Weighs in on Alpha Tau Medical Ltd.'s FY2023 Earnings (NASDAQ:DRTS)Alpha Tau Medical Ltd. (NASDAQ:DRTS - Free Report) - Equities researchers at Cantor Fitzgerald upped their FY2023 earnings estimates for Alpha Tau Medical in a note issued to investors on Tuesday, August 29th. Cantor Fitzgerald analyst K. Kluska now anticipates that the company will post earningsAugust 24, 2023 | finance.yahoo.comAlpha Tau Medical to Participate in September Investor ConferencesAugust 17, 2023 | finance.yahoo.comAlpha Tau Announces Robust Long-Term Safety and Efficacy Data from Multiple Clinical Trials of Alpha DaRTAugust 8, 2023 | marketbeat.com35,070 Shares in Alpha Tau Medical Ltd. (NASDAQ:DRTS) Purchased by ProVise Management Group LLCProVise Management Group LLC purchased a new stake in Alpha Tau Medical Ltd. (NASDAQ:DRTS - Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 35,070 shares of the company's stock, valued at approximaAugust 2, 2023 | finance.yahoo.comAlpha Tau Medical to Present at the Emerging Growth Conference on August 9th, 2023July 2, 2023 | marketbeat.comETF Managers Group LLC Takes $190,000 Position in Alpha Tau Medical Ltd. (NASDAQ:DRTS)ETF Managers Group LLC bought a new stake in Alpha Tau Medical Ltd. (NASDAQ:DRTS - Free Report) in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 66,326 shares of the company's stock, valued at approximately $May 29, 2023 | marketbeat.comEquities Analysts Set Expectations for Alpha Tau Medical Ltd.'s Q2 2023 Earnings (NASDAQ:DRTS)Alpha Tau Medical Ltd. (NASDAQ:DRTS - Get Rating) - Analysts at HC Wainwright reduced their Q2 2023 earnings per share estimates for Alpha Tau Medical in a report released on Wednesday, May 24th. HC Wainwright analyst Y. Chen now expects that the company will earn ($0.12) per share for the quarteMay 25, 2023 | markets.businessinsider.comH.C. Wainwright Keeps Their Buy Rating on Alpha Tau Medical Ltd (DRTS)May 24, 2023 | finance.yahoo.comAlpha Tau Medical to Participate in June Investor ConferencesMay 23, 2023 | msn.comRecap: Alpha Tau Medical Q1 EarningsMay 22, 2023 | finance.yahoo.comShould You Buy Alpha Tau Medical (DRTS) Ahead of Earnings?May 18, 2023 | markets.businessinsider.comAlpha Tau Medical Ltd (DRTS) Receives a Buy from H.C. WainwrightMay 17, 2023 | finance.yahoo.comAlpha Tau Expands its Alpha DaRT Treatment to Vulvar Cancer in Novel Clinical Trial with Cambridge UniversityMay 11, 2023 | finance.yahoo.comAlpha Tau Announces the Publication of its US Multicenter Pilot Skin Cancer Trial Results in JAMA Network OpenMay 3, 2023 | finance.yahoo.comAlpha Tau Medical to Present at Guggenheim Radiopharmaceuticals DayApril 24, 2023 | msn.comAlpha Tau Medical a new buy at HC Wainwright on proprietary radiation therapyMarch 8, 2023 | finance.yahoo.comAlpha Tau Announces Alpha DaRT™ Treatment of First Two Patients in its Pivotal Multicenter Recurrent Skin Cancer (ReSTART) TrialMarch 1, 2023 | finance.yahoo.comAlpha Tau Announces Health Canada Authorization for Alpha DaRT Clinical Trial for the Treatment of Liver Metastases Get Alpha Tau Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for DRTS and its competitors with MarketBeat's FREE daily newsletter. Email Address What is Nvidia doing on June 10? June 10th is pivotal for Nvidia’s “Silent Partners” (Ad)A small handful of companies are working with Nvidia to help ensure that this pivot is a massive success. We call them Nvidia’s “Silent Partners.” Click here to find out who they are. DRTS Media Mentions By Week DRTS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DRTS News Sentiment▼1.290.76▲Average Medical News Sentiment DRTS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DRTS Articles This Week▼20▲DRTS Articles Average Week Get Alpha Tau Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for DRTS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: FNA News PLSE News SRDX News SIBN News IRMD News BVS News OFIX News ANIK News TMCI News OSUR News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:DRTS) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpha Tau Medical Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.